Top Markets
Coin of the day
Q32 Bio Inc. Q32 Bio Inc.

Q32 Bio Inc.

QTTB
Classifica tra le azioni #14023
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to... Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-associated vasculitis. Additionally, Q32 Bio is advancing Bempikibart (ADX-914), a fully human monoclonal antibody antagonist against interleukin-7 receptor alpha. Currently in Phase II trials, Bempikibart aims to recalibrate adaptive immune responses by inhibiting signaling pathways involving interleukin-7 and thymic stromal lymphopoietin, offering potential treatment for atopic dermatitis and alopecia areata. Founded in 2017 and headquartered in Waltham, Massachusetts, Q32 Bio Inc. adopted its current name in April 2020, having previously operated as AdMIRx Inc.
Prezzo delle azioni
$14.86
Ultima sincronizzazione: 2026-08-31
Capitalizzazione di mercato
$442.29M
Variazione (1 giorno)
-1.13%
Variazione (1 anno)
769.01%
Paese
US
Scambia Q32 Bio Inc. (QTTB)

Categoria

Storico del prezzo dell'azione per Q32 Bio Inc. (QTTB)
Prezzo di chiusura più alto: $15.70 il 2026-08-01

Prezzo di chiusura più basso: $336.24 il 2018-03-01
Storico del prezzo dell'azione di Q32 Bio Inc. dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 104.51%
2025 -69.67%
2024 6.01%
2023 -59.20%
2022 -67.95%
2021 -61.63%
2020 -44.79%
2019 -12.56%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.58 -11.06%
AU
$138.80 476.17%
US
$749.90 5.10%
CH